Immunocore Holdings Stock Buy Hold or Sell Recommendation

IMCR Stock  USD 28.80  0.53  1.87%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Immunocore Holdings is 'Hold'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell Immunocore Holdings within the specified time frame.
  
Check out Immunocore Holdings Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.
Note, we conduct extensive research on individual companies such as Immunocore and provide practical buy, sell, or hold advice based on investors' constraints. Immunocore Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Execute Immunocore Holdings Buy or Sell Advice

The Immunocore recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Immunocore Holdings. Macroaxis does not own or have any residual interests in Immunocore Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Immunocore Holdings' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Immunocore HoldingsBuy Immunocore Holdings
Hold

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Investor Sentiment

InterestedDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Immunocore Holdings has a Risk Adjusted Performance of (0.03), Jensen Alpha of (0.07), Total Risk Alpha of 0.2014 and Treynor Ratio of (0.27)
Our trade recommendations module complements current analysts and expert consensus on Immunocore Holdings. It analyzes the firm potential to grow using all fundamental, technical, and market related data available at the time. To make sure Immunocore Holdings is not overpriced, please check out all Immunocore Holdings fundamentals, including its price to sales, book value per share, working capital, as well as the relationship between the cash and equivalents and number of employees . Given that Immunocore Holdings has a number of shares shorted of 7.42 M, we strongly advise you to confirm Immunocore Holdings market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Immunocore Holdings Trading Alerts and Improvement Suggestions

The company reported the previous year's revenue of 310.2 M. Net Loss for the year was (51.09 M) with profit before overhead, payroll, taxes, and interest of 299.7 M.
Immunocore Holdings has a poor financial position based on the latest SEC disclosures
Over 94.0% of the company shares are owned by institutional investors
Latest headline from thelincolnianonline.com: Needham Company LLC Reaffirms Buy Rating for Immunocore

Immunocore Holdings Returns Distribution Density

The distribution of Immunocore Holdings' historical returns is an attempt to chart the uncertainty of Immunocore Holdings' future price movements. The chart of the probability distribution of Immunocore Holdings daily returns describes the distribution of returns around its average expected value. We use Immunocore Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Immunocore Holdings returns is essential to provide solid investment advice for Immunocore Holdings.
Mean Return
-0.11
Value At Risk
-4.18
Potential Upside
4.79
Standard Deviation
2.53
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Immunocore Holdings historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Immunocore Stock Institutional Investors

The Immunocore Holdings' institutional investors refer to entities that pool money to purchase Immunocore Holdings' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
Shares
Armistice Capital, Llc2024-12-31
1.2 M
Fiera Capital Corporation2024-12-31
780 K
Citigroup Inc2024-12-31
632.9 K
Two Sigma Advisers, Llc2024-12-31
604.9 K
Groupama Asset Management2024-12-31
600 K
Millennium Management Llc2024-12-31
573.4 K
Deep Track Capital, Lp2024-12-31
519.4 K
Principal Financial Group Inc2024-12-31
502.9 K
Massachusetts Financial Services Company2024-12-31
459 K
T. Rowe Price Investment Management,inc.2024-12-31
6.7 M
Wellington Management Company Llp2024-12-31
6.6 M
Note, although Immunocore Holdings' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Immunocore Holdings Cash Flow Accounts

202020212022202320242025 (projected)
Capital Expenditures3.1M1.0M2.2M5.4M5.2M3.7M
Change To Netincome3.4M33.3M45.4M22.1M25.4M26.7M
Investments467K(367K)193K4.8M(355.1M)(337.4M)
Change In Cash55.8M146.0M114.3M40.2M13.1M12.4M
Depreciation9.0M7.0M6.1M4.1M4.2M5.0M
Net Income(74.1M)(131.5M)(41.2M)(43.4M)(51.1M)(53.6M)
End Period Cash Flow129.7M321.1M401.6M442.6M455.7M279.4M
Free Cash Flow(63.6M)(130.8M)(33.5M)(2.5M)20.9M21.9M
Other Non Cash Items38.5M(14.9M)(7.4M)4.0M(6.4M)(6.1M)

Immunocore Holdings Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Immunocore Holdings or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Immunocore Holdings' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Immunocore stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
-0.07
β
Beta against Dow Jones0.42
σ
Overall volatility
2.51
Ir
Information ratio -0.0024

Immunocore Holdings Volatility Alert

Immunocore Holdings exhibits very low volatility with skewness of 0.19 and kurtosis of -0.22. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Immunocore Holdings' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Immunocore Holdings' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Immunocore Holdings Fundamentals Vs Peers

Comparing Immunocore Holdings' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Immunocore Holdings' direct or indirect competition across all of the common fundamentals between Immunocore Holdings and the related equities. This way, we can detect undervalued stocks with similar characteristics as Immunocore Holdings or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Immunocore Holdings' fundamental indicators could also be used in its relative valuation, which is a method of valuing Immunocore Holdings by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Immunocore Holdings to competition
FundamentalsImmunocore HoldingsPeer Average
Return On Equity-0.14-0.31
Return On Asset-0.0408-0.14
Profit Margin(0.16) %(1.27) %
Operating Margin(0.02) %(5.51) %
Current Valuation1.05 B16.62 B
Shares Outstanding50.07 M571.82 M
Shares Owned By Insiders5.23 %10.09 %
Shares Owned By Institutions94.01 %39.21 %
Number Of Shares Shorted7.42 M4.71 M
Price To Book3.98 X9.51 X
Price To Sales4.65 X11.42 X
Revenue310.2 M9.43 B
Gross Profit299.7 M27.38 B
EBITDA(70.46 M)3.9 B
Net Income(51.09 M)570.98 M
Cash And Equivalents208.06 M2.7 B
Cash Per Share4.74 X5.01 X
Total Debt41.71 M5.32 B
Debt To Equity0.41 %48.70 %
Current Ratio3.98 X2.16 X
Book Value Per Share7.21 X1.93 K
Cash Flow From Operations26.06 M971.22 M
Short Ratio38.58 X4.00 X
Earnings Per Share(1.02) X3.12 X
Target Price64.03
Number Of Employees49318.84 K
Beta0.8-0.15
Market Capitalization1.44 B19.03 B
Total Asset1.01 B29.47 B
Retained Earnings(795.76 M)9.33 B
Working Capital717.68 M1.48 B
Net Asset1.01 B
Note: Acquisition by Travis Coy of 274033 shares of Immunocore Holdings at 29.5 subject to Rule 16b-3 [view details]

Immunocore Holdings Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Immunocore . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Immunocore Holdings Buy or Sell Advice

When is the right time to buy or sell Immunocore Holdings? Buying financial instruments such as Immunocore Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Immunocore Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run SRI Sustainable Growth Thematic Idea Now

SRI Sustainable Growth
SRI Sustainable Growth Theme
Socially responsible investments that include companies making a positive, sustainable or social impact and exclude those making a negative impact. The SRI Sustainable Growth theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SRI Sustainable Growth Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Immunocore Stock Analysis

When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.